Company
Headquarters: Nanjing, China
Employees: 5,062
CEO: Mr. Jian Jun Zhou
CN¥6.77 Billion
CNY as of July 1, 2025
US$944.6 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Roche | $260.54 B |
| Novartis | $243.50 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
NanJing Pharmaceutical Company Limited engages pharmaceutical wholesale and retail businesses in China. It also operates approximately 510 pharmacy retail stores and an e-commerce platform. The company was founded in 1951 and is based in Nanjing, China.
NanJing Pharmaceutical Company Ltd has the following listings and related stock indices.
Stock: SSE: 600713 wb_incandescent